NVRO Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	444 111
Średni wolumen	488 806
Kapitalizacja rynkowa	419.67M
EPS	$0 ( 2024-05-07 )
Następna data zysków	( $0 ) 2024-07-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.50
ATR14	$0.0140 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Thornal Kevin R	Sell	24 233	Common Stock
2024-04-11	Grossman D Keith	Sell	3 986	Common Stock
2024-04-04	Rashid Kashif	Sell	479	Common Stock
2024-03-31	Kosaraju Sridhar	Buy	1 090	Common Stock
2024-03-31	Demane Michael F	Buy	1 817	Common Stock

INSIDER POWER
60.42
Last 97 transactions
Buy: 980 834 \| Sell: 269 822

Wolumen Korelacja

Długi: 0.44 (neutral)

Krótki: -0.62 (weak negative)

Signal:(48.936) Neutral

Nevro Corp Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nevro Corp Korelacja - Waluta/Towar

0.14
( neutral )

0.79
( moderate )

0.00
( neutral )

0.52
( weak )

0.00
( neutral )

-0.24
( neutral )

Nevro Corp Finanse

Annual	2023
Przychody:	$425.17M
Zysk brutto:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2023
Przychody:	$425.17M
Zysk brutto:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2022
Przychody:	$406.37M
Zysk brutto:	$276.37M (68.01 %)
EPS:	$0.0850

FY	2021
Przychody:	$386.91M
Zysk brutto:	$266.04M (68.76 %)
EPS:	$-3.77

Financial Reports:

No articles found.

Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.